BioCentury
ARTICLE | Finance

Biotech investor, banker and analyst personnel changes

February 13, 2012 8:00 AM UTC

James Tyree is retiring as president of Abbott Biotech Ventures Inc., a venture capital arm of Abbott Laboratories (NYSE:ABT).

Gregory Grunberg joined Longitude Capitalas a managing director. He was a principal at Rho Ventures. Longitude has $325 million under management...